Dave Muoio
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.
Certain healthcare use cases are ripe for AI, but still must provide a human touch to truly benefit patient experience.
The company is tripling its physician pool by the end of April, and has launched a new patient dashboard.
From 2000 to 2017, the number of registered clinical trials featuring CGMs, apps and other connected devices rose at a 34% CAGR, according to new data from Harvard researchers.
The new investment brings the medical cybersecurity startup's total raise to $30 million.
Also: FDA clears Nuvo Group's fetal and maternal heart monitor for pregnant women; Innovaccer, Sanitas USA launch virtual COVID-19 care app.
The anonymized, aggregated GPS data is collected from mobile devices that have opted into location-tracking services.
The raise will help SteadyMD further develop its technology platform and online services.
Bodysphere's announcement was spread across a number of mainstream news and social media channels before the company released a statement that explained its misunderstanding.
The PPG-based feature automatically measures the wearer's heart rhythm every five minutes, and will be ready for integration with a range of devices later this year.